Chevy Chase Trust Holdings LLC Sells 19,902 Shares of Kenvue Inc. (NYSE:KVUE)

Chevy Chase Trust Holdings LLC lessened its stake in Kenvue Inc. (NYSE:KVUE - Free Report) by 1.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,007,928 shares of the company's stock after selling 19,902 shares during the quarter. Chevy Chase Trust Holdings LLC owned 0.05% of Kenvue worth $21,519,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently modified their holdings of KVUE. AMF Tjanstepension AB increased its holdings in Kenvue by 187.3% in the 3rd quarter. AMF Tjanstepension AB now owns 120,477 shares of the company's stock worth $2,787,000 after buying an additional 78,540 shares in the last quarter. Exchange Traded Concepts LLC increased its holdings in Kenvue by 371.7% in the 3rd quarter. Exchange Traded Concepts LLC now owns 29,887 shares of the company's stock worth $691,000 after buying an additional 23,551 shares in the last quarter. Vontobel Holding Ltd. increased its holdings in Kenvue by 13.4% in the 3rd quarter. Vontobel Holding Ltd. now owns 22,594 shares of the company's stock worth $523,000 after buying an additional 2,677 shares in the last quarter. AlphaMark Advisors LLC bought a new stake in Kenvue in the 3rd quarter worth about $77,000. Finally, Sumitomo Mitsui DS Asset Management Company Ltd increased its holdings in Kenvue by 1.8% in the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 198,300 shares of the company's stock worth $4,587,000 after buying an additional 3,428 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Analysts Set New Price Targets

A number of research firms have issued reports on KVUE. Citigroup cut their price target on Kenvue from $25.00 to $21.00 and set a "neutral" rating for the company in a research note on Wednesday, January 15th. Deutsche Bank Aktiengesellschaft downgraded Kenvue from a "buy" rating to a "hold" rating and cut their price target for the company from $25.00 to $24.00 in a research note on Thursday, December 12th. Canaccord Genuity Group cut their price objective on Kenvue from $27.00 to $24.00 and set a "buy" rating for the company in a research note on Friday, February 7th. Piper Sandler upgraded Kenvue from a "neutral" rating to an "overweight" rating and boosted their price objective for the company from $21.00 to $26.00 in a research note on Monday, January 6th. Finally, Royal Bank of Canada reiterated a "sector perform" rating and set a $24.00 price objective on shares of Kenvue in a research note on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat, Kenvue currently has an average rating of "Hold" and a consensus price target of $23.00.

Kenvue Price Performance

Shares of KVUE traded up $0.26 during mid-day trading on Wednesday, hitting $22.26. 14,194,931 shares of the stock were exchanged, compared to its average volume of 13,257,708. The company has a market cap of $42.68 billion, a PE ratio of 42.00, a price-to-earnings-growth ratio of 2.57 and a beta of 1.45. Kenvue Inc. has a 52-week low of $17.67 and a 52-week high of $24.46. The firm has a 50-day moving average of $21.30 and a two-hundred day moving average of $22.12. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The company reported $0.26 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. On average, equities analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, February 26th. Stockholders of record on Wednesday, February 12th will be given a dividend of $0.205 per share. This represents a $0.82 annualized dividend and a dividend yield of 3.68%. The ex-dividend date of this dividend is Wednesday, February 12th. Kenvue's dividend payout ratio is currently 154.72%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.